Search Results - "Attig, Sebastian"
-
1
CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis
Published in Journal of immunotherapy (1997) (01-06-2017)“…B-cell acute lymphoblastic leukemia (B-ALL) is the commonest childhood cancer and the prognosis of children with relapsed or therapy refractory disease remains…”
Get full text
Journal Article -
2
Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL
Published in Oncoimmunology (31-12-2023)“…Despite massive improvements in the treatment of B-ALL through CART-19 immunotherapy, a large number of patients suffer a relapse due to loss of the targeted…”
Get full text
Journal Article -
3
FLT3 Ligand Enhances the Cancer Therapeutic Potency of Naked RNA Vaccines
Published in Cancer research (Chicago, Ill.) (01-10-2011)“…Intranodal immunization with antigen-encoding naked RNA may offer a simple and safe approach to induce antitumor immunity. RNA taken up by nodal dendritic…”
Get full text
Journal Article -
4
The gut microbiota instructs the hepatic endothelial cell transcriptome
Published in iScience (22-10-2021)“…The gut microbiota affects remote organ functions but its impact on organotypic endothelial cell (EC) transcriptomes remains unexplored. The liver endothelium…”
Get full text
Journal Article -
5
Improved method to retain cytosolic reporter protein fluorescence while staining for nuclear proteins
Published in Cytometry. Part A (01-07-2014)“…Staining of transcription factors (TFs) together with retention of fluorescent reporter proteins is hindered by loss of fluorescence using current available…”
Get full text
Journal Article -
6
A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols
Published in Journal of translational medicine (11-07-2011)“…The introduction of antibody markers to identify undesired cell populations in flow-cytometry based assays, so called DUMP channel markers, has become a…”
Get full text
Journal Article -
7
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Published in Nature (London) (03-09-2020)“…Treating patients who have cancer with vaccines that stimulate a targeted immune response is conceptually appealing, but cancer vaccine trials have not been…”
Get full text
Journal Article -
8
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Published in Nature (London) (16-06-2016)“…The development of a nanoparticle RNA vaccine is reported that preferentially targets dendritic cells after systemic administration, and is shown to provide…”
Get full text
Journal Article -
9
Cytomegalovirus Infection
Published in Annals of the New York Academy of Sciences (01-10-2007)“…: The human immune system evolved to defend the organism against pathogens, but is clearly less well able to do so in the elderly, resulting in greater…”
Get full text
Journal Article -
10
Studies of S-adenosylhomocysteine-hydrolase polymorphism in a Croatian population
Published in Journal of human genetics (01-01-2006)“…Recently, a proven case of human S-adenosylhomocysteine-hydrolase (SAHH) deficiency was reported in a Croatian boy. As molecular analysis of the SAHH gene in…”
Get full text
Journal Article -
11
Cytomegalovirus infection: a driving force in human T cell immunosenescence
Published in Annals of the New York Academy of Sciences (01-10-2007)“…The human immune system evolved to defend the organism against pathogens, but is clearly less well able to do so in the elderly, resulting in greater morbidity…”
Get full text
Journal Article -
12
Gating Harmonization Guidelines for Intracellular Cytokine Staining Validated in Second International Multiconsortia Proficiency Panel Conducted by Cancer Immunotherapy Consortium (CIC/CRI)
Published in Cytometry. Part A (01-01-2021)“…Results from the first gating proficiency panel of intracellular cytokine staining (ICS) highlighted the value of using a consensus gating approach to reduce…”
Get full text
Journal Article -
13
A shared tumor-antigen RNA-lipoplex vaccine with/without anti-PD1 in patients with checkpoint-inhibition experienced melanoma
Published in Journal of clinical oncology (20-05-2020)“…Abstract only 3136 Background: Cancer vaccines are considered unsuitable for patients with advanced tumours and have not been clinically successful. Methods:…”
Get full text
Journal Article -
14
Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas
Published in Cancer research (Chicago, Ill.) (01-11-2009)“…Renal cell carcinoma is frequently infiltrated by cells of the immune system. This makes it important to understand interactions between cancer cells and…”
Get full text
Journal Article -
15
Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients
Published in International journal of cancer (01-07-2012)“…CD4+ T cells have been shown to be crucial for the induction and maintenance of cytotoxic T cell responses and to be also capable of mediating direct tumor…”
Get full text
Journal Article -
16
mTOR inhibition improves antitumor effects of vaccination with antigen-encoding RNA
Published in Cancer immunology research (01-12-2013)“…Vaccination with in vitro transcribed RNA encoding tumor antigens is an emerging approach in cancer immunotherapy. Attempting to further improve RNA vaccine…”
Get more information
Journal Article -
17
Abstract CT156: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Therapeutic vaccination with tumor antigen-encoding RNAs is being investigated in various clinical trials. Typically, the RNA vaccine is administered…”
Get full text
Journal Article -
18
Abstract CT034: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent melanoma immunotherapy
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Therapeutic vaccination with tumor antigen-encoding RNAs by local administration is currently being successfully employed in various clinical trials…”
Get full text
Journal Article -
19
Functional TCR retrieval from single antigen-specific human T cells reveals multiple novel epitopes
Published in Cancer immunology research (01-12-2014)“…The determination of the epitope specificity of disease-associated T-cell responses is relevant for the development of biomarkers and targeted immunotherapies…”
Get more information
Journal Article -
20
Generation of TCR-engineered T cells and their use to control the performance of T cell assays
Published in The Journal of immunology (1950) (15-06-2015)“…The systematic assessment of the human immune system bears huge potential to guide rational development of novel immunotherapies and clinical decision making…”
Get full text
Journal Article